InvestorsHub Logo
Followers 56
Posts 2583
Boards Moderated 0
Alias Born 01/23/2013

Re: None

Sunday, 01/22/2017 5:29:10 PM

Sunday, January 22, 2017 5:29:10 PM

Post# of 504
INFI - Baker Brothers have taken a position in INFI. Trading at around cash value as of the close on Friday. Zero priced in for current cancer indication treatment for tumors. Only company working on this and have a collaboration with Bristol-Myers for Opdivo. P1 results were outstanding IMO. Big gap towards $5.00 to fill. Gaps always get filled. This is way undervalued as it sits. Too many big name funds in here to ignore, plus insider buying.